Showing results (311-320 of 118,277) with videos related to
Sort By:
Pageof 11,828
Nanoscale|April 13, 2018
F-Doped carbon nano-onion films as scaffold for highly efficient and stable Li metal anodes: a novel laser direct-write processDhanya Puthusseri, Malik Wahid, Aniruddha Basu, et al.BMJ Global Health|May 30, 2019
Self-collection of samples as an additional approach to deliver testing services for sexually transmitted infections: a systematic review and meta-analysisYasmin Ogale, Ping Teresa Yeh, Caitlin E Kennedy, et al.Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 23, 2008
Peculiarities of the adsorption kinetics of mixed convex plus concave contour objectsPradip B Shelke, S B Ogale, M D Khandkar, et al.Nanotechnology|April 13, 2013
CdTe-TiO2 nanocomposite: an impeder of bacterial growth and biofilmHaribhau Gholap, Rajendra Patil, Prasad Yadav, et al.Small (Weinheim an Der Bergstrasse, Germany)|July 22, 2014
From waste paper basket to solid state and Li-HEC ultracapacitor electrodes: a value added journey for shredded office paperDhanya Puthusseri, Vanchiappan Aravindan, Bihag Anothumakkool, et al.Ultramicroscopy|December 17, 2010
Investigation of wüstite (Fe1-xO) by femtosecond laser assisted atom probe tomographyM Bachhav, R Danoix, F Danoix, et al.Rheumatology and Therapy|October 18, 2016
Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another BiologicStephen S Johnston, Donna McMorrow, Amanda M Farr, et al.Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non-small cell lung cancerIbrahim M Abbass, Daniel M Sheinson, Anuj Shah, et al.Pharmacoeconomics - Open|December 18, 2025
Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer ScreeningCarolina Heuser, Michael K Gould, Eran Choman, et al.Rheumatology and Therapy|October 18, 2016
Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid ArthritisMartin J Bergman, Eric P Elkin, Sarika Ogale, et al.Pageof 11,828